Research Paper Volume 16, Issue 6 pp 5123—5148
The comprehensive landscape of prognosis, immunity, and function of the GLI family by pan-cancer and single-cell analysis
Figure 5. Expression of GLI1, GLI2, and GLI3 with OS, PFI, and DSS in tumor patients. Forest plots of hazard ratios of GLI1, GLI2, and GLI3 in OS (A–C), PFI (D–F), and DSS (G–I).